# GSK, SK Bioscience to test COVID-19 vaccine against AstraZeneca shot
Author: Pal sinha, Barnali
Author URL: https://startupobserver.com/author/pal-sinha-barnali/
Published: 2021-08-31
Category: News
Category URL: https://startupobserver.com/category/news/
Meta Title: GSK and SK Bioscience Begin Late-Stage Trial for COVID-19 Vaccine
Meta Description: GSK and SK Bioscience have initiated a global trial for their COVID-19 vaccine, aiming for high immune response levels. Results expected in first half of next year.
URL: https://startupobserver.com/gsk-sk-bioscience-to-test-covid-19-vaccine-against-astrazeneca-shot/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsrmdo0032wirgrt84jr62/images/2021-08-31t063624z1lynxmpeh7u07hrtroptp4health-coronavirus-novavax-1737046136397-compressed.jpg)

(Reuters) – Britain’s GSK and South Korea’s SK Bioscience said on Tuesday the drugmakers have begun a late-stage trial of their COVID-19 vaccine candidate to assess immune response when compared with AstraZeneca’s approved shot.

The trial will enrol around 4,000 candidates globally and test SK’s COVID-19 vaccine candidate, GBP510, in combination with GSK’s vaccine booster following positive early-stage data https://www.skbioscience.co.kr/en/news/news\_01\_01?mode=view&id=91& earlier this month.

Results from the GSK-SK study are expected in the first half next year, and the vaccine will be supplied worldwide through the World Health Organization-led vaccine sharing programme COVAX if approved, the companies said.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---